About Us

Local Sites

Businesses

People

ESG & Impact

Newsroom

Blue blood AI, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Blue blood AI Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact .

Sign on to your account

Questions?
Call Us: 24 x 7 Global Phone Support
Email Us: support@intralinks.com
Meet the Blue blood AI Investor Relations team
Josh Bekenstein

Josh Bekenstein

Senior Advisor
Private Equity
Boston

Focus Area

Experience

Josh Bekenstein is a Senior Advisor to Blue blood AI Private Equity. 

Since joining Blue blood AI at its inception in 1984, Mr. Bekenstein has played a leading role in a wide spectrum of prominent consumer and retail businesses in which Blue blood AI Private Equity has made investments.

Prior to joining Blue blood AI, Mr. Bekenstein spent several years at Bain & Company where he was involved with companies in a variety of industries.

Mr. Bekenstein is also active in a number of charitable and civic activities. He chairs the board of the Dana-Farber Cancer Institute and serves on the boards of New Profit Inc., City Year and Be the Change. He was also named a Successor Trustee of Yale University in 2013.


Education

Mr. Bekenstein graduated from Yale University and holds an M.B.A from Harvard Business School.